Type 2 diabetes impairs brain metabolic and mitochondrial homeostasis and is associated with oxidative stress and neuroinflammation. The intensity-dependent neuroprotective effects of exercise, particularly interval training, on brain mitochondrial quality control and related metabolic signaling are not fully defined. This study evaluated how differing interval training intensities influence hippocampal and cortical mitophagy, upstream metabolic signaling pathways, oxidative stress indices, and inflammatory cytokines in a rat model of type 2 diabetes.
Fifty male rats were allocated to five groups (n = 10 per group): healthy control (HC), diabetic control (DC), diabetic + low-intensity interval training (LIIT), diabetic + moderate-intensity interval training (MIIT), and diabetic + high-intensity interval training (HIIT). The experimental approach compared sedentary diabetic animals with diabetic animals undergoing interval training at three intensities to examine intensity-dependent outcomes in the hippocampus and cortex. Statistical significance for reported comparisons was set at p < 0.05.
After the intervention, hippocampal and cortical tissues were assayed for a set of predefined molecular and biochemical markers:
These markers were chosen to assess mitochondrial quality control (mitophagy), energy-sensing signaling, redox balance, and neuroinflammatory state.
Compared with diabetic controls, moderate- and high-intensity interval training (MIIT and HIIT) activated AMPK-ULK1 signaling and suppressed mTOR signaling in both the hippocampus and cortex. Activation of AMPK and phosphorylation of ULK1 are consistent with enhanced energy sensing and initiation of autophagic processes. Suppression of mTOR further supports a shift toward catabolic, autophagy-permissive signaling in trained diabetic animals. The hippocampus exhibited particularly notable activation, indicating regional sensitivity to intensity-dependent metabolic signaling changes.
MIIT and HIIT increased markers indicative of enhanced mitophagy relative to diabetic controls. Specifically, elevations in PINK1 and Parkin and an increased LC3-II/I ratio were reported alongside reductions in p62, consistent with improved mitochondrial clearance and autophagic flux. The changes were more pronounced in the hippocampus than the cortex, aligning with the stronger AMPK-ULK1 activation documented in that region.
Interval training improved the redox profile in an intensity-dependent manner. MIIT and HIIT were associated with reduced lipid peroxidation markers (MDA and 4-HNE) and enhanced antioxidant defenses (increased SOD, CAT, and TAC) compared with diabetic controls. These adaptations paralleled increases in mitophagy and metabolic signaling that favor mitochondrial quality control, suggesting coordinated improvements in mitochondrial function and oxidative balance with higher training intensities.
Pro-inflammatory cytokines TNF-α, IL-6, and IL-1β were attenuated following interval training, with greater reductions observed with MIIT and HIIT than with LIIT. Overall, reported outcomes followed an intensity-dependent pattern described by the authors as LIIT < MIIT < HIIT for the magnitude of benefit across metabolic signaling, mitophagy, oxidative stress, and inflammatory readouts.
In this experimental model of type 2 diabetes, interval training produced neuroprotective adaptations that scaled with exercise intensity. Moderate- and high-intensity interval protocols more robustly activated AMPK-ULK1 signaling, suppressed mTOR, enhanced mitophagy markers, improved redox balance, reduced lipid peroxidation, and attenuated neuroinflammation compared with low-intensity interval training and diabetic controls. These coordinated changes suggest interval training intensity can modulate brain mitochondrial quality control and inflammatory state in diabetes, with the hippocampus showing particular responsiveness.
The authors conclude that MIIT and HIIT may offer greater neuroprotective benefits than LIIT in the context of experimental type 2 diabetes, but they emphasize that these effects require confirmation in broader experimental contexts.
Details such as exact training protocols, duration, and additional experimental parameters beyond markers measured were not reported in the abstract. The study is an animal model (male rats), so translation to humans and to diverse biological contexts requires further work. The authors note the need for confirmation of findings across broader experimental conditions.
Interval training produced intensity-dependent improvements in brain metabolic signaling, mitophagy, oxidative balance, and neuroinflammation in a rat model of type 2 diabetes, with moderate and high intensities showing the largest effects. Confirmation in additional studies and models is necessary before extrapolating to clinical recommendations.